Pain Amelioration in Patients with Neuropathic Pain: An Emerging Role of Lacosamide besides its Role as an Anti Epileptic Agent

Arzneimittelforschung 2012; 62(08): 400
DOI: 10.1055/s-0032-1316375

Letter to the Editor

S. Kapoor

¹Private Practice, Mechanicsville, VA, USA

References
1 Shah S, Vasantharaju SG, Arumugam K et al. Development of a Sensitive Bioanalytical Method for the Quantification of Lacosamide in Rat Plasma. Application to Preclinical Pharmacokinetics Studies in Rats
2 Geis C, Beyreuther BK, Stohr T et al. Lacosamide has protective disease modifying properties in experimental vincristine neuropathy. Neuropharmacology 2011; 61: 600-607
3 Shaibani A, Fares S, Selam JL et al. Lacosamide in painful diabetic neuropathy: an 18-week double-blind placebo-controlled trial. J Pain 2009; 10: 818-828
4 Hao JX, Stohr T, Selve N et al. Lacosamide, a new anti-epileptic, alleviates neuropathic pain-like behaviors in rat models of spinal cord or trigeminal nerve injury. Eur J Pharmacol 2006; 553: 135-140
5 Errington AC, Stohr T, Heers C et al. The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels. Mol Pharmacol 2008; 73: 157-169
6 Garcia-Escriva A, Lopez-Hernandez N, Gil-Cortes C. Treatment of neuropathic pain with lacosamide. Rev Neurol 2012; 54: 167-172
7 Beyreuther B, Callizot N, Stohr T. Antinociceptive efficacy of lacosamide in the monosodium iodoacetate rat model for osteoarthritis pain. Arthritis Res Ther 2007; 9: R14
8 Wymer JP, Simpson J, Sen D et al. Lacosamide SP742 Study Group. Efficacy and safety of lacosamide in diabetic neuropathic pain: an 18-week double-blind placebo-controlled trial of fixed-dose regimens. Clin J Pain 2009; 25: 376-385